Qualifications: Billie Bonevski is a health behaviour scientist and Professor at the University of Newcastle (UON), Faculty of Health and Medicine. She is currently a NHMRC Career Development Fellow (CDF Level 2: 2014-2018) and the recipient of the prestigious Faculty of Health and Medicine’s Gladys M Brawn Research Award. Bonevski completed a scholarship-supported PhD at the University of Newcastle, in the Discipline of Behavioural Science in Relation to Medicine after gaining a Psychology Honours degree (1st Class with WH Ward Prize for Best Applied Thesis). Immediately following her PhD she completed a World Health Organisation-sponsored postdoctoral travel fellowship with Cancer Research UK and the Cochrane Collaboration’s Tobacco Addiction Review Group, both based at Oxford University.
Research Support: Overall: $17M, NHMRC: $11M. CI on 14 NHMRC grants (7 as CIA), one ARC Linkage grant and a number of specialty grants including National Heart Foundation, National Stroke Foundation, RACGP, VicHealth, NSW Ministry of Health and Cancer Institute NSW. In 2016 awarded funding (CIA, $2.3M) in international Global Alliance in Chronic Disease (GACD) NHMRC scheme and CIB on international Global Research Award on Nicotine Dependence (GRAND) in 2017. Income last 5 years: $10.4M from NHMRC project, partnership and targeted grants alone. She has also attracted over $1M in fellowship funding (NHMRC and CINSW).
Research outputs and citations: Over 250 career publications including 132 peer reviewed articles in top discipline journals; 67% published in last 5 years. Ranked first in the world for peer reviewed publications on ‘tobacco smoking cessation and disadvantage’, contributing 12% of all publications on this topic worldwide; 2243 total citations and citation ranking = 7 out of 228 researchers, 10% of all citations in this area, worldwide (last 5 years, ISI Web of Science).
International recognition: Founding President of Oceania chapter of peak international Society for Research in Nicotine & Tobacco (SRNT). 7 international keynotes, symposia and chairs (SRNT, Oceania Tobacco Control, World Cancer Congress). Invited to contribute to discipline leading journals: Addiction (invited commentary), Frontiers in Psychiatry (Lead Editor, Special Issue), Expert Review of Respiratory Medicine (invited review), comment in Lancet (2017). Awarded Thoracic Society of Australia and New Zealand’s President’s Prize for tobacco control (2016).
Translation/impact: CAPHIA award-winning research into reactions of high risk groups to plain cigarette packs was cited in UK and German parliamentary submissions for plain packaging. Research revealing gender and socioeconomic inequalities in exposure to second-hand smoke in multi-unit housing led to changes in NSW housing by-laws. Research with Cancer Council NSW (CCNSW) led to implementation of Tackling Tobacco Program in >200 community social services in NSW, and now in Victoria, WA and Queensland, reaching >28,000 service clients (featured in current CCNSW Annual Report). As a member of advisory groups for government and other stakeholders, I have influenced policy and delivery of smoking cessation care throughout Australia.